Drug · DIN 02566273
IDENOS
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 8, 2026; first marketed September 8, 2026.
- Drug Identification Number (DIN)
- 02566273
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Denosumab M05BX04
- Class
- Human
- Record last updated
- September 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DENOSUMAB | 120 MG | 1.7 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 11, 2026: NOC 37133New Drug Submission (NDS)